| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |